Dietary Supplement Listing Bill introduced in the House

Rep. Maxine Dexter has introduced the Dietary Supplement Listing Act of 2026 in the House, aiming to require dietary supplement manufacturers to register their products and ingredients with the FDA, improve transparency, and create a product database. The bill is supported by some industry groups advocating for modernization and greater oversight, but faces opposition from others concerned about regulatory burdens and industry innovation. The legislation follows previous, unsuccessful Senate efforts led by Sen. Dick Durbin, and controversy continues over the number of adverse events linked to supplements. While the bill’s future in Congress is uncertain, it reflects ongoing debate about balancing consumer safety, transparency, and industry interests.